肼氮嗪
金黄色葡萄球菌
微生物学
抗菌剂
万古霉素
抗生素
医学
药理学
化学
生物
细菌
内科学
遗传学
血压
作者
Francisca Bruna Stefany Aires do Nascimento,Lívia Gurgel do Amaral Valente Sá,João Batista de Andrade Neto,Lisandra Juvêncio da Silva,Daniel Sampaio Rodrigues,Vitória Pessoa de Farias Cabral,Amanda Dias Barbosa,Lara Elloyse Almeida Moreira,Camille R Braga Vasconcelos,Bruno Coêlho Cavalcanti,Maria Erivanda França Rios,Jacilene Silva,Emmanuel Silva Marinho,Hélcio Silva dos Santos,Jacó RL de Mesquita,Marina Duarte Pinto Lobo,Manoel Odorico de Moraes,Hélio Vitoriano Nobre Júnior,Cecília Rocha da Silva
出处
期刊:Future Microbiology
[Future Medicine]
日期:2024-01-31
被引量:1
标识
DOI:10.2217/fmb-2023-0160
摘要
Background: Staphylococcus aureus is a human pathogen responsible for high mortality rates. The development of new antimicrobials is urgent. Materials & methods: The authors evaluated the activity of hydralazine along with its synergism with other drugs and action on biofilms. With regard to action mechanisms, the authors evaluated cell viability, DNA damage and molecular docking. Results: MIC and minimum bactericidal concentration values ranged from 128 to 2048 μg/ml. There was synergism with oxacillin (50%) and vancomycin (25%). Hydralazine reduced the viability of biofilms by 50%. After exposure to hydralazine 2× MIC, 58.78% of the cells were unviable, 62.07% were TUNEL positive and 27.03% presented damage in the comet assay (p < 0.05). Hydralazine showed affinity for DNA gyrase and TyrRS. Conclusion: Hydralazine is a potential antibacterial.
科研通智能强力驱动
Strongly Powered by AbleSci AI